Literature DB >> 9462247

Evaluation of 2-SP transport medium for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by two automated amplification systems and culture for chlamydia.

O Dubuis1, M Gorgievski-Hrisoho, D Germann, L Matter.   

Abstract

AIMS: To assess the performance of 2-sucrose-phosphate based transport medium (2-SP) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by an automated commercial polymerase chain reaction (PCR) and ligase chain reaction (LCR) compared to centrifugation culture on McCoy cells for C trachomatis. Second, to compare both amplification systems for initial diagnostic testing of a low prevalence population for sexually transmitted diseases.
METHODS: Four hundred and eighty one consecutive urogenital and conjunctival specimens were examined. All tests were performed on the same specimen collected with a dacron swab and transported in 2-SP medium. Samples that were positive by culture or by both PCR and LCR were considered to be true positives.
RESULTS: The prevalences of C trachomatis and of N gonorrhoeae were 2.7% and 0.4%, respectively. PCR had a resolved sensitivity and specificity of 100% and 99.8%, respectively, for C trachomatis, and 100% and 98.9%, respectively, for N gonorrhoeae. LCR was 100% sensitive and specific for both pathogens. The resolved sensitivity of the shell vial assay was 85%. No culture positive sample would have been missed by PCR or LCR. The inhibition rate for PCR was 4.8%.
CONCLUSIONS: 2-SP medium proved to be suitable for both PCR and LCR. It is not limited to any one test manufacturer and allows the performance of amplification techniques and viral and chlamydia culture from the same specimen. The LCR was more reliable than PCR on initial testing. However, hands on time is longer, and no amplification control is available for LCR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462247      PMCID: PMC500322          DOI: 10.1136/jcp.50.11.947

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

Review 2.  Sexually transmitted diseases in the 1990s. Global epidemiology and challenges for control.

Authors:  P Piot; M Q Islam
Journal:  Sex Transm Dis       Date:  1994 Mar-Apr       Impact factor: 2.830

3.  Early detection of chlamydial inclusions combining the use of cycloheximide-treated McCoy cells and immunofluorescence staining.

Authors:  B J Thomas; R T Evans; G R Hutchinson; D Taylor-Robinson
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

4.  Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids.

Authors:  J B Mahony; K E Luinstra; J W Sellors; M A Chernesky
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

5.  Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction.

Authors:  G J van Doornum; M Buimer; M Prins; C J Henquet; R A Coutinho; P K Plier; S Tomazic-Allen; H Hu; H Lee
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Amplification of Chlamydia trachomatis DNA by ligase chain reaction.

Authors:  B J Dille; C C Butzen; L G Birkenmeyer
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  C A Bass; D L Jungkind; N S Silverman; J M Bondi
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

8.  Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction.

Authors:  M J Loeffelholz; C A Lewinski; S R Silver; A P Purohit; S A Herman; D A Buonagurio; E A Dragon
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Ophthalmia neonatorum in a trachoma endemic area.

Authors:  P Datta; E Frost; R Peeling; S Masinde; S Deslandes; C Echelu; I Wamola; R C Brunham
Journal:  Sex Transm Dis       Date:  1994 Jan-Feb       Impact factor: 2.830

10.  Analysis of the entire nucleotide sequence of the cryptic plasmid of Chlamydia trachomatis serovar L1. Evidence for involvement in DNA replication.

Authors:  C Hatt; M E Ward; I N Clarke
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

View more
  5 in total

1.  Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens.

Authors:  C H Livengood; J W Wrenn
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Evaluation of the Roche Neisseria gonorrhoeae 16S rRNA PCR for confirmation of AMPLICOR PCR-positive samples and comparison of its diagnostic performance according to storage conditions and preparation of endocervical specimens.

Authors:  E Van Dyck; H Smet; L Van Damme; M Laga
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

3.  Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey.

Authors:  César P Cárcamo; Pablo E Campos; Patricia J García; James P Hughes; Geoff P Garnett; King K Holmes
Journal:  Lancet Infect Dis       Date:  2012-08-08       Impact factor: 25.071

4.  Rapid and Cost-Efficient Enterovirus Genotyping from Clinical Samples Using Flongle Flow Cells.

Authors:  Carole Grädel; Miguel Angel Terrazos Miani; Maria Teresa Barbani; Stephen L Leib; Franziska Suter-Riniker; Alban Ramette
Journal:  Genes (Basel)       Date:  2019-08-29       Impact factor: 4.096

5.  Whole-Genome Sequencing of Human Enteroviruses from Clinical Samples by Nanopore Direct RNA Sequencing.

Authors:  Carole Grädel; Miguel A Terrazos Miani; Christian Baumann; Maria Teresa Barbani; Stefan Neuenschwander; Stephen L Leib; Franziska Suter-Riniker; Alban Ramette
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.